Publications by authors named "Cal Andreou"

Claim this Profile
T
The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer.
Laurence Klotz, Laurent Boccon-Gibod, Neal D Shore, Cal Andreou, Bo-Eric Persson

BJU Int· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A double-blind randomized dose-response study comparing daily doses of 5, 10 and 15 mg controlled-release oxybutynin: balancing efficacy with severity of dry mouth.
Jaques Corcos, Richard Casey, Allan Patrick, Cal Andreou, Paula C Miceli

BJU Int· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis